iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
For current clinical care, donated human blood is safer and more effective than synthetic blood substitutes. Donated red cells, platelets and plasma are regulated therapies with established indications, compatibility testing, infection screening and transfusion monitoring. Synthetic blood is not a single product; most candidates reproduce only one or a few blood functions, and no oxygen-carrying substitute has FDA approval for routine transfusion in the United States.
That conclusion does not mean donated blood is risk-free or that synthetic-blood research has failed. It means the alternatives remain investigational while developers work on oxygen transport, clotting, storage and portability. Earlier clinical trials of cell-free hemoglobin products also identified serious cardiovascular and organ-toxicity concerns that must be solved before synthetic products can replace donated blood.
What “synthetic blood” actually means
Blood is a coordinated system, not merely a bag of oxygen-carrying fluid. Red blood cells transport oxygen and carbon dioxide; platelets help form clots; plasma carries proteins, electrolytes, nutrients, hormones and immune factors. A substitute that performs one task may be useful in a narrow setting but cannot automatically replace every component of a transfusion.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Researchers use “synthetic blood” or “blood substitute” for several different technologies:
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
- Hemoglobin-based oxygen carriers (HBOCs): purified or modified hemoglobin molecules intended to carry oxygen without intact red cells.
- Perfluorocarbon emulsions: synthetic fluids that can dissolve and transport oxygen and carbon dioxide.
- Engineered erythrocytes: laboratory-made particles or cells designed to mimic selected red-cell functions.
- Platelet surrogates: particles or biologic constructs intended to support clot formation.
- Plasma surrogates: engineered fluids that attempt to replace selected volume or plasma functions.
Most candidates target one or a few functions rather than the complete biology of whole blood. A product can therefore be promising as a temporary oxygen carrier, a component of hemorrhage treatment or a research platform without being a universal replacement for donated blood.
How the two options compare
| Question | Donated blood | Synthetic substitutes |
|---|---|---|
| Clinical status | Established therapy with validated transfusion indications and monitoring | Mostly investigational; no FDA-approved oxygen-carrying substitute is commercially available for routine transfusion |
| Functions supplied | Red-cell, platelet and plasma components can be selected and combined to meet a patient’s need | Usually reproduces one or a few functions, such as oxygen transport or volume expansion |
| Safety controls | Donor screening, infectious-disease testing, blood grouping, compatibility testing, standards, inspection and adverse-event monitoring | Requires product-specific toxicology, dose, efficacy and regulatory evaluation; prior HBOC trials produced important safety signals |
| Storage and distribution | Depends on component-specific storage, inventory management and compatible blood availability | Designed to reduce donor dependence and potentially improve portability or shelf life, but logistical advantages do not establish clinical safety |
| Evidence base | Decades of clinical use and guidelines for component transfusion | No substitute has demonstrated the efficacy and safety needed to replace natural blood in vivo |
Why donated blood remains the clinical standard
It supplies the functions patients actually need
Hospitals do not treat every bleeding or anemia problem with “whole blood” by default. They select components: red cells for inadequate oxygen-carrying capacity, platelets for thrombocytopenia or platelet dysfunction, and plasma when clotting factors or other plasma proteins are required. This component approach lets clinicians match treatment to the physiological deficit.
Its risks are managed through several independent safeguards
Donated blood is not risk-free. Transfusion reactions, bacterial contamination, residual infection risk, circulatory overload and immune complications remain possible. The safety advantage comes from layers of control rather than from an assumption that every unit is harmless. The World Health Organization describes donated blood and plasma products as critical to health care and emphasizes quality-assured screening for infections, blood grouping and compatibility testing. National regulators and hospitals add standards, inspection, traceability, bedside checks and adverse-event reporting.
Recommended Free Tools
Its performance is clinically understood
Clinicians have established dosing practices, compatibility rules, monitoring protocols and indications for blood components. They can measure hemoglobin, platelet counts, coagulation tests and patient response before deciding whether another component is needed. That body of evidence is a major practical advantage over a substitute whose behavior may change with dose, formulation, disease state or organ function.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Why synthetic products have raised safety concerns
Cell-free hemoglobin behaves differently from hemoglobin inside a red cell
In a normal red cell, the cell membrane and surrounding biochemical systems help control where hemoglobin travels and how it interacts with blood vessels. When hemoglobin is released into plasma, it can undergo oxidative reactions and bind or remove signaling molecules that regulate vascular tone. The FDA has described toxicity from cell-free hemoglobin, including vasoactive effects that can cause vasoconstriction and hypertension, as well as downstream risks such as heart attack and stroke.
Serious outcomes appeared in randomized-trial evidence
A 2008 JAMA meta-analysis of randomized trials of cell-free hemoglobin substitutes reported a relative risk of mortality of 1.30 (95% confidence interval, 1.05–1.61). The same analysis reported a relative risk of myocardial infarction of 2.71 (95% confidence interval, 1.67–4.40). These figures describe the analyzed substitute trials; they are not estimates of the risk of donated-blood transfusion generally and should not be applied to every future formulation.
Other organs may also be exposed
Free hemoglobin and its breakdown products can create oxidative stress and place demands on the kidneys and other organs. Modifying the hemoglobin molecule, enclosing it in a carrier or changing its size may reduce one mechanism of toxicity, but each formulation still needs its own pharmacology, dose-ranging studies and clinical-outcome evidence. The FDA has stated that these complications have prevented full development of HBOC products despite attempts to eliminate their toxic effects.
Is synthetic blood available yet?
Not as a broadly approved replacement for donated blood. An NIH regulatory guide states that no FDA-approved oxygen-carrying blood substitute is commercially available. Reviews published in 2024 and 2025 likewise report that no hemoglobin-based oxygen carrier has obtained U.S. FDA approval for clinical use and that no substitute has yet achieved the efficacy required for in-vivo replacement of natural blood.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Some investigational products may be studied under clinical-trial protocols or considered under jurisdiction-specific emergency or compassionate-use rules. Availability, eligibility and legal status can differ by country and by product. A trial product should therefore never be treated as a consumer therapy or assumed to be obtainable for routine surgery, anemia or home use.
Can a synthetic product replace a transfusion?
For routine patient care, no current synthetic product can replace the full range of transfusion components. A candidate that transports oxygen might address part of the red-cell problem, but it would not automatically provide platelets, clotting factors, immune proteins or the precise regulation supplied by intact cells and plasma.
Even for oxygen transport, “works in a laboratory” is not enough. A substitute must deliver oxygen to tissues without causing harmful vasoconstriction, oxidative injury, kidney damage, immune effects or cardiovascular events. Researchers must also establish a clinically useful duration of action, predictable dosing, interactions with other treatments and outcomes that are at least as good as accepted transfusion practice.
Situations in which research could be valuable
- Severe bleeding before compatible blood is available: a stable, portable oxygen carrier could theoretically provide temporary support during transport or early resuscitation.
- Remote, military or disaster settings: products that tolerate less demanding storage could help where refrigeration and blood inventories are difficult to maintain.
- Rare blood-group logistics: a validated universal or broadly compatible product could reduce delays caused by cross-matching.
- Shortages: scalable manufacturing could supplement, but not automatically replace, donor collections.
These are potential uses, not established indications. Each would require evidence from controlled trials and regulatory review.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
Why logistics make synthetic blood attractive
Donated components have finite shelf lives and require collection from volunteers, infectious-disease testing, refrigeration or freezing, inventory rotation and compatibility management. Supply can vary by region, season, disasters and changes in donation rates. Those constraints explain the appeal of a manufactured product that could be produced at scale, stored longer, transported more easily and used without immediate donor matching.
However, solving storage or supply does not solve physiology. A product can be shelf-stable yet unsafe in the circulation, or convenient to administer yet unable to support clotting. The relevant comparison is not “easy to stock” versus “hard to stock”; it is whether the complete benefit-risk profile is better for a defined patient and indication.
How clinicians decide what to use today
- Identify the problem. Clinicians determine whether the patient has blood loss, anemia, impaired clotting, low platelets, shock or another condition that transfusion might address.
- Choose the needed component. Red cells, platelets, plasma or combinations are selected according to laboratory results, bleeding severity and clinical guidelines.
- Check compatibility and risk. Blood grouping, antibody testing, cross-matching and review of prior reactions help reduce preventable harm.
- Transfuse with monitoring. Vital signs and symptoms are observed during and after administration so reactions or overload can be treated promptly.
- Use an investigational substitute only under an authorized protocol. If a synthetic candidate is being studied, the trial consent, eligibility rules, dosing plan and safety monitoring govern its use; it is not an interchangeable retail alternative.
What evidence would make a substitute clinically credible?
A future product would need more than a favorable oxygen-binding curve. Regulators and clinicians would look for:
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
- Controlled evidence showing survival and organ outcomes that are no worse than accepted transfusion strategies for the intended indication.
- Acceptable rates of hypertension, vasoconstriction, myocardial infarction, stroke, kidney injury, immune reactions and other serious adverse events.
- Predictable pharmacokinetics, a practical duration of effect and a clearly defined dose.
- Reliable manufacturing, sterility and batch-to-batch consistency.
- Compatibility with surgery, intensive-care treatment, anticoagulants and other emergency therapies.
- Clear instructions for storage, administration, monitoring and management of adverse reactions.
Because “synthetic blood” covers multiple technologies, evidence for one formulation cannot be transferred automatically to another. A safer result with a platelet surrogate, for example, would not establish that an HBOC is safe.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
What the next generation of research is trying to solve
Current development programs span oxygen carriers, engineered red-cell mimics, platelet surrogates and plasma-like products. Some aim to stabilize hemoglobin or confine it within a protective carrier; others focus on particles that participate in clot formation or fluids that support circulation. Fieldable hemorrhage-resuscitation programs, including efforts described in the 2025 biosynthetic-surrogate literature, reflect the operational need for products that can reach patients quickly.
The central challenge is to combine useful oxygen delivery or hemostasis with the safety profile of intact blood components. Longer storage, portability and scalable manufacturing would be valuable only after rigorous human studies demonstrate that patients benefit without unacceptable cardiovascular, renal or inflammatory harm.
Practical answer to the safety question
If “safer” means the option with the strongest evidence and established safeguards for ordinary transfusion care, donated blood is the answer today. If “safer” means free of all transfusion hazards, neither option qualifies: donated blood has known residual risks, while synthetic products have unresolved or previously demonstrated toxicities that keep them investigational.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Repair Windows errors before they cause bigger problems3Fix the driver behind crashes, sound loss and screen glitchesIf a clinician mentions a synthetic product, ask which specific technology is involved, whether it is approved for the proposed use in your jurisdiction, what evidence supports that indication, what alternatives are available and how adverse effects will be monitored. The phrase “synthetic blood” alone does not identify a treatment or establish its safety.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
